I Halder1, J Champlin2, L Sheu3, B H Goodpaster2, S B Manuck3, R E Ferrell4, M F Muldoon2. 1. Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: halderi@upmc.edu. 2. Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 3. Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA. 4. Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
BACKGROUND AND AIMS: Habitual physical activity is understood to help prevent type 2 diabetes and atherosclerotic cardiovascular disease via beneficial effects on both metabolism and the vascular system. However, individuals do not have uniform cardiometabolic responses to physical activity. Here we explore the extent to which variation in the proliferator-activated receptor-alpha (PPARα) gene, which modulates carbohydrate and lipid metabolism, vascular function, and inflammation, predicts the overall cardiometabolic risk (CMR) profile of individuals engaging in various levels of physical activity. METHODS AND RESULTS: 917 unrelated, community volunteers (52% female, of Non-Hispanic European ancestry) aged 30-54 years, participated in the cross-sectional study. Subjects were genotyped for 5 single nucleotide polymorphisms in the PPARα gene, from which common haplotypes were defined. A continuous measure of CMR was calculated as an aggregate of 5 traditional risk factors: waist circumference, resting blood pressure, fasting serum triglycerides, HDL-cholesterol and glucose. Regression models were used to examine the main and interactive effects of physical activity and genetic variation on CMR. One common PPARα haplotype (H-23) was associated with a higher CMR. This association was moderated by daily physical activity (B = -0.11, SE = 0.053, t = -2.05, P = 0.04). Increased physical activity was associated with a steeper reduction of CMR in persons carrying the otherwise detrimental H-23 haplotype. CONCLUSIONS: Variations in the PPARα gene appear to magnify the cardiometabolic benefits of habitual physical activity.
BACKGROUND AND AIMS: Habitual physical activity is understood to help prevent type 2 diabetes and atherosclerotic cardiovascular disease via beneficial effects on both metabolism and the vascular system. However, individuals do not have uniform cardiometabolic responses to physical activity. Here we explore the extent to which variation in the proliferator-activated receptor-alpha (PPARα) gene, which modulates carbohydrate and lipid metabolism, vascular function, and inflammation, predicts the overall cardiometabolic risk (CMR) profile of individuals engaging in various levels of physical activity. METHODS AND RESULTS: 917 unrelated, community volunteers (52% female, of Non-Hispanic European ancestry) aged 30-54 years, participated in the cross-sectional study. Subjects were genotyped for 5 single nucleotide polymorphisms in the PPARα gene, from which common haplotypes were defined. A continuous measure of CMR was calculated as an aggregate of 5 traditional risk factors: waist circumference, resting blood pressure, fasting serum triglycerides, HDL-cholesterol and glucose. Regression models were used to examine the main and interactive effects of physical activity and genetic variation on CMR. One common PPARα haplotype (H-23) was associated with a higher CMR. This association was moderated by daily physical activity (B = -0.11, SE = 0.053, t = -2.05, P = 0.04). Increased physical activity was associated with a steeper reduction of CMR in persons carrying the otherwise detrimental H-23 haplotype. CONCLUSIONS: Variations in the PPARα gene appear to magnify the cardiometabolic benefits of habitual physical activity.
Authors: Kristine M Shedd; Kathy B Hanson; D Lee Alekel; Daniel J Schiferl; Laura N Hanson; Marta D Van Loan Journal: Med Sci Sports Exerc Date: 2007-12 Impact factor: 5.411
Authors: Amanda K Golembesky; Marilie D Gammon; Kari E North; Jeannette T Bensen; Jane C Schroeder; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella Journal: Carcinogenesis Date: 2008-06-26 Impact factor: 4.944
Authors: John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster Journal: Am J Physiol Endocrinol Metab Date: 2008-03-04 Impact factor: 4.310
Authors: Tingjing Ke; Rajkumar Dorajoo; Yi Han; Chiea-Chuen Khor; Rob M van Dam; Jian-Min Yuan; Woon-Puay Koh; Jianjun Liu; Yik Ying Teo; Daniel Y T Goh; E Shyong Tai; Tien Yin Wong; Ching-Yu Cheng; Yechiel Friedlander; Chew-Kiat Heng Journal: Ann Hum Genet Date: 2016-09 Impact factor: 1.670
Authors: Ruth J F Loos; James M Hagberg; Louis Pérusse; Stephen M Roth; Mark A Sarzynski; Bernd Wolfarth; Tuomo Rankinen; Claude Bouchard Journal: Med Sci Sports Exerc Date: 2015-06 Impact factor: 5.411